AuroBlog - Aurous Healthcare Clinical Trials blog
JULY 28, 2024
The Indian pharmaceutical industry is working to take advantage of Generative AI potential to transform drug discovery. Functions such as establishing connections between the causative pathways and showing the genetic predispositions have the potential to enable successful interventions and revert disease progression.
Pharmaceutical Technology
JULY 28, 2024
SecureCHEK AI is a Category Award Winner in four areas in the 2024 Pharmaceutical Technology Excellence Awards
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuroBlog - Aurous Healthcare Clinical Trials blog
JULY 28, 2024
Researchers have discovered patterns in the brain that reflect the effectiveness of deep brain stimulation therapy for obsessive–compulsive disorder (OCD), potentially leading to improvements in the way that the condition is handled individually for each case.
pharmaphorum
JULY 28, 2024
The CHMP has backed LEO Pharma's delgocitinib for chronic hand eczema, considered to be one of its top pipeline prospects
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Patent Watch
JULY 28, 2024
Patient advocacy groups have become increasingly influential in the pharmaceutical industry, particularly in the development of generic drugs.
BioSpace
JULY 28, 2024
Under the deal announced Monday with the California biotech, German pharma Boehringer Ingelheim is gaining access to novel immune checkpoint inhibitors designed to activate the immune system to fight cancer cells.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
BioSpace
JULY 28, 2024
Fatalities are an unfortunate reality of clinical trials. How can companies best protect themselves?
Trialfacts
JULY 28, 2024
Contents About the Study Why Participate? Your Rights Who Can Participate? More Study Details About the Research Centre: Location Research Centre: Monash University Location: 770 Blackburn Rd, Clayton VIC 3168 Lead Researcher: Antonio Verdejo-Garcia HREC: This study has been reviewed and approved by the Monash University Human Ethics Research Committee About the Study Did you know that personalised treatments for Alcohol Use Disorder (AUD) could revolutionise recovery success rates?
BioSpace
JULY 28, 2024
The regulator on Friday warned healthcare providers and patients about adverse events linked with dosing errors from compounded versions of Novo Nordisk’s weight-loss and diabetes drugs.
Drug Patent Watch
JULY 28, 2024
This chart shows the pharmaceutical companies with the most powder dosed drugs. For a different perspective, see the most popular dosage types.
JAMA Internal Medicine
JULY 28, 2024
This case report describes a man in his 40s with evidence of malignant J wave syndrome on electrocardiography.
Drug Patent Watch
JULY 28, 2024
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.
Roots Analysis
JULY 28, 2024
In 1967, renowned zoologist Desmond Morris quoted, “Flawless skin is the most universally desired human feature”. According to him, social convention dictates that the well-being of human health and fertility are indicative of an even-toned, clear skin with a radiant complexion. While cosmetic procedures can effectively target specific aging concerns like deep wrinkles, sagging skin, and volume loss, they may not comprehensively improve the overall skin quality.
Drug Patent Watch
JULY 28, 2024
ALOXI (palonosetron hydrochloride) Helsinn hlthcare Patent: 7,947,725 Expiration: Jul 30, 2024 See More … For more information on how DrugPatentWatch […] Source
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Expert insights. Personalized for you.
184 
Let's personalize your content